Neonatal Systemic AAV Induces Tolerance to CNS Gene Therapy in MPS I Dogs and Nonhuman Primates
Open Access
- 1 August 2015
- journal article
- Published by Elsevier BV in Molecular Therapy
- Vol. 23 (8), 1298-1307
- https://doi.org/10.1038/mt.2015.99
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Whole body correction of mucopolysaccharidosis IIIA by intracerebrospinal fluid gene therapyJCI Insight, 2013
- Hepatic Gene Transfer in Neonatal Mice by Adeno-Associated Virus Serotype 8 VectorHuman Gene Therapy, 2012
- Disease-specific non–reducing end carbohydrate biomarkers for mucopolysaccharidosesNature Chemical Biology, 2012
- Impact of Pre-Existing Immunity on Gene Transfer to Nonhuman Primate Liver with Adeno-Associated Virus 8 VectorsHuman Gene Therapy, 2011
- Systemic Administration of AAV8-α-galactosidase A Induces Humoral Tolerance in Nonhuman Primates Despite Low Hepatic ExpressionMolecular Therapy, 2011
- Evaluation of Adeno-Associated Viral Vectors for Liver-Directed Gene Transfer in DogsHuman Gene Therapy, 2011
- Neonatal helper-dependent adenoviral vector gene therapy mediates correction of hemophilia A and tolerance to human factor VIIIProceedings of the National Academy of Sciences of the United States of America, 2011
- Eradication of neutralizing antibodies to factor VIII in canine hemophilia A after liver gene therapyBlood, 2010
- Heparin cofactor II‐thrombin complex and dermatan sulphate:chondroitin sulphate ratio are biomarkers of short‐ and long‐term treatment effects in mucopolysaccharide diseasesJournal of Inherited Metabolic Disease, 2010
- Immunomodulatory Gene Therapy Prevents Antibody Formation and Lethal Hypersensitivity Reactions in Murine Pompe DiseaseMolecular Therapy, 2010